Диссертация (1147802), страница 36
Текст из файла (страница 36)
Nemeroff // J Clin Psychiatry. – 1994. – Vol. 55 Suppl. –Р. 3-15.320. Neutel J.M. Improving patient compliance: a major goal in the managementof hypertension / J.M. Neutel, D.H. Smith // J Clin Hipertenns (Greenwich). –2003. – Vol. 5 (2). – P. 127-132.321. Ngoh L.N. Health literacy: a barrier to pharmacist-patient communicationand medication adherence / L.N. Ngoh // J Am Pharm Assoc (2003)[Electronic resource]. – 2009. – Vol. 49 (5).
– e132-146. – URL:https://www.researchgate.net/publication/26807089_Health_literacy_A_barrier_to_pharmacist-patient_communication_and_medication_adherence – Date ofaccess: 10.10.2014.322. Nichols M. European Cardiovascular Disease Statistics 2012: EuropeanHeart Network [Electronic resource]. / M. Nichols, N. Townsend,205P. Scarborough et al. – Sophia Antipolis; 2012.
Brussels and European Societyof Cardiology. URL: http://www.ehnheart.org/cvd-statistics.html – Date ofaccess: 10.09.2014.323. Nunes M.I. The relationship between quality of life and adherence totreatment / M.I. Nunes // Curr Hypertens Rep. – 2001. – Vol. 3 (6). – Р. 462-465.324. O’Connor G.T. Differences between men and women in hospital mortalityassociated with coronary artery bypass graft surgery: the Northern NewEngland Cardiovascular Disease Study Group / G.T. O’Connor, J.R.
Morton,M.J. Diehl et al. // Circulation. – 1993. – Vol. 88 (5 Pt 1). – P. 2104-2110.325. Oosterom-Calo R. Determinants of adherence to heart failure medication: asystematic literature review / R. Oosterom-Calo R, A.J. van Ballegooijen,C.B. Terwee et al. // Heart Fail Rev. – 2013. – Vol. 18 (4). – Р.
409-427.326. Osterberg L. Adherence to medication / L. Osterberg, T. Blaschke // N EnglJ Med. – 2005. – Vol. 353 (5). – Р. 487-497.327. Paschal Angelia M. Factors associated with medication adherence in patientswith epilepsy and recommendations for improvement / M. Paschal Angelia,E. Rush Sarah, T. Sadler // Epilepsy & Behavior.
– 2014. – Vol. 31. – Р. 346-350.328. Pasma A. Factors associated with adherence to pharmaceutical treatment forrheumatoid arthritis patients: a systematic review / A. Pasma, A. van’t Spijker,J.M. Hazes et al. // Semin Arthritis Rheum – 2013. – Vol. 43 (1). – P. 18-28.329. Patel B.V. Adherence with single-pill amlodipine/atorvastatin vs a two-pillregimen / B.V. Patel, R.S. Leslie, P.
Thiebaud et al. // Vasc Health RiskManag – 2008. – Vol. 4 (3). – Р. 673-681.330. Patel R.P. Factors affecting medication adherence in hypertensive patients /R.P. Patel, S.D. Taylor // Ann Pharmacother. – 2002. – Vol. 36 (1). – P. 40-45.331. Phillips L.A. Assessing theoretical predictors of long-term medicationadherence: Patients’ treatment-related beliefs, experiential feedback and habitdevelopment / L.A. Phillips, H. Leventhal, E.A. Leventhal // Psychology &Health. – 2013.
– Vol. 28 (10). – P. 1135-1151.206332. Piette J.D. The role of patient–physician trust in moderating medicationnonadherence due to cost pressures / J.D. Piette, M. Heisler, S. Krein et al. //Archives of Internal Medicine. – 2005. – Vol. 165 (15). – Р. 1749-1755.333. Pignone M. Use of lipid lowering drugs for primary prevention of coronaryheart disease: meta-analysis of randomized trials / M. Pignone, C. Phillips,C. Mulrow // BMJ – 2000. – Vol. 321 (7267). – Р. 983-986.334.
Pinsky J.L. The Framingham Disability Study: relationship of variouscoronary heart disease manifestations to disability in older persons living inthe community / J.L. Pinsky, A.M. Jette, L.G. Branch el al. // Am J PublicHealth. – 1990. – Vol. 80 (11). – Р. 1363-1367.335. Reisner S.L.
A review of HIV antiretroviral adherence and interventionstudies among HIV-infected youth / S.L. Reisner, M.J. Mimiaga, M. Skeer etal. // Top. HIV Med. – 2009. – Vol. 17 (1). – P. 14-25.336. Rendón-Medina M.A. Desconocimiento del nombre del medicamento comofactor de riesgo relativo de incumplimiento del tratamiento en pacientes conhipertensión arterial sistémica de poblaciones rurales / M.A.
Rendón-Medina,N. Ávila-López, A. Becerril-Ayala et al. // Med Int Méx. – 2014. – Vol. 30. –Р. 240-246.337. Rivelli S. Depression and ischemic heart disease: what have we learned fromclinical trials? / S. Rivelli, W. Jiang // Curr Opin Cardiol –2007. – Vol. 22 (4).– P. 286-291.338. Ross S.D. Clinical outcomes in statin treatment trials: a meta-analysis / S.D.Ross, I.E. Allen, J.E.
Connelly et al. // Arch Intern Med – 1999. – Vol. 159(15). – Р. 1793-1802.339. Sackett D.L. Randomised clinical trial of strategies for improvingmedication compliance in primary hipertension / D.L. Sackett, R.B. Haynes,E.S. Gibson, et al. // Lancet. – 1975. – Vol. 1 (7918). – Р. 1205-1207.207340. Sanson-Fisher R. Factors affecting nonadherence with antibiotics /R. Sanson-Fisher, J. Bowman, S. Armstrong // Diagn Microbiol Infect Dis.
–1992. – Vol. 15 (4 Suppl). – Р. 103S-109S.341. Sarriff A. A study of patients’ self-interpretation of prescription instructions/ A. Sarriff, N.A. Aziz, Y. Hassan, et al. // J Clin Pharm Ther. – 1992. –Vol. 17 (2). – Р. 125-128.342. Scheier M.F. Optimism, coping, and health: assessment and implications ofgeneralized outcome expectancies / M.F. Scheier, С.S.
Carver // HealthPsychology. – 1985. – Vol. 4 (3). – P. 219-247.343. Schoen M.W. Comparison of Adherence to Guideline-Based CholesterolTreatment Goals in Men Versus Women / M.W. Schoen, R.G. Tabak, J. Salaset al. // Am J Cardiol. – 2016. – Vol. 117 (1). – P. 48-53.344. Schrijvers L.H. Barriers and motivators of adherence to prophylactictreatment in haemophilia: a systematic review / L.H.
Schrijvers, N. Uitslager,M.J. Schuurmans, et al. // Haemophilia. – 2013. – Vol. 19 (3). – Р. 355-361.345. Schroeder K. Interventios for improving adherence to treatment in patientswith high blood pressure in ambulatory settings / K. Schroeder, T. Fahey,S. Ebrahim // Cochrane Database Syst Rev [Electronic resource]. – 2004.
–Vol. 2. – CD004804. – URL: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004804/abstract;jsessionid=68B3F9DD26BF59BEA4E5F04F30AC2AC6.f02t03. – Date of access: 10.10.2014.346. Sever P.S. Prevention of coronary and stroke events with atorvastatin inhypertensive patients who have average or lower-than-average cholesterolconcentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--LipidLowering Arm (ASCOT-LLA): a multicentre randomized controlled trial /P.S.
Sever, B. Dahlöf, N.R. Poulter et al. // Lancet. – 2003. – Vol. 361 (9364).– Р. 1149-1158.208347. Shaw E. Factors associated with noncompliance of patients takingantihypertensive medications / E. Shaw, J.G. Anderson, M. Maloney et al. //Hosp Pharm. – 1995. – Vol. 30 (3). – P. 201-203, 206-207.348. Sher T. The partners for life program: a couples approach to cardiac riskreduction / T.
Sher, L. Braun, A. Domas et al. // Family Process. – 2014. –Vol. 53 (1). – P. 131-149.349. Sifneos P.E. Short-Term Psychotherapy and Emotional Crisis / P.E. Sifneos/ Cambridge, Mass.: Harvard University Press, 1972.350. Simpson S.H. A meta-analysis of the association between adherence to drugtherapy and mortality / S.H. Simpson, D.T. Eurich, S.R. Majumdar et al. //BMJ [Electronic resource]. – 2006. – Vol. 333 (7557). – URL:http://www.bmj.com/content/333/7557/15 – Date of access: 10.09.2014.351. Sin M.-K.
Personal characteristics, health status, physical activity, andquality of life in cardiac rehabilitation participants / M.-K. Sin, B. Sanderson,M. Weaver et al. // International Journal of Nursing Studies. – 2004. – Vol. 41(2). – P. 173-181.352. Slijkhuis W. A historical perspective towards a non-invasive treatment forpatients with atherosclerosis / W. Slijkhuis, W. Mali, Y.
Appelman // NethHeart J. – 2009. – Vol. 17 (4). – P. 140-144.353. Sousa J.E. New frontiers in cardiology: drug-eluting stents: Part I /J.E. Sousa, P.W. Serruys, M.A. Costa // Circulation. – 2003. – Vol. 107 (17). –Р. 2274-2279.354. Stanton A.L. Determinants of adherence to medical regimens byhypertensive patients / A.L. Stanton // J Behav Med. – 1987.
– Vol. 10 (4). –P. 377-394.355. Steiner J.F. The assessment of refill compliance using pharmacy records:methods, validity, and applications / J.F. Steiner, A.V. Prochazka // J ClinEpidemiol. – 1997. – Vol. 50 (1). – Р. 105-116.209356. Stilley C.S.
Psychological and cognitive function: predictors of adherencewith cholesterol lowering treatment / C.S. Stilley, S. Sereika, M.F. Muldoon etal. // Ann Behav Med. – 2004. – Vol. 27 (2). – P. 117-124.357. Swenson J.R. Assessment of quality of life in patients with cardiac disease:the role of psychosomatic medicine / J.R. Swenson, J.J. Clinch // J PsychosomRes. – 2000.
– Vol. 48 (4-5). – P. 405-415.358. Takiya L.N. Meta-analysis of interventions for medication adherence toantihypertensives / L.N. Takiya, A.M. Peterson, R.S. Finley // AnnPharmacother. – 2004. – Vol. 38 (10). – Р. 1617-1624.359. Theofilou P. A literature review to investigate the link between psychosocialcharacteristics and treatment adherence in cancer patients / P. Theofilou,H. Panagiotaki // Oncology Reviews [Electronic resource].
– 2012. – Vol. 6(1). – URL: doi: 10.4081/oncol.2012.e5. – Date of access: 10.09.2014.360. Thomas F. Combined effects of systolic blood pressure and serumcholesterol on cardiovascular mortality in young (<55 years) men and women /F. Thomas, K. Bean, L. Guize et al. // Eur Heart J. – 2002. – Vol. 23 (7). –Р. 528-535.361. Todaro J.F. Effect of negative emotions on frequency of coronary heartdisease (The Normative Aging Study) / J.F. Todaro, B.J. Shen, R. Niaura et al.// Am J Cardiol. – 2003. – Vol. 92 (8). – Р. 901-906.362.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
